Peri-Implantitis: The Two-Component Biological Approach
Peri-implantitis treatment outcomes are limited by the gap between mechanical decontamination and biological re-establishment of the peri-implant tissue interface. Mechanical therapy addresses biofilm but does not modulate the NFκB-driven inflammatory environment or restore the soft tissue collar around the implant. A peptide adjunct addresses both biological components.
What mechanical therapy does
Mechanical decontamination of the implant surface — air abrasion, laser, ultrasonic, or rotary debridement — addresses the biofilm component of peri-implantitis. Published outcome data show clinical attachment improvement is variable and recurrence rates remain meaningfully high. The mechanical approach does not address the inflammatory environment that re-establishes after debridement.
What mechanical therapy does not do
Two biological components persist after debridement and drive recurrence: (1) the NFκB-mediated inflammatory environment in peri-implant tissue, with sustained IL-1β, TNF-α, and RANKL signaling; (2) the absence of a competent soft tissue collar — fibroblast-mediated collagen synthesis and ECM organization — that establishes a healthy biological seal at the implant interface.
OptiOral Seal protocol position
OptiOral Seal is a precision sulcular delivery gel applied to the peri-implant sulcus via micro-syringe (23-gauge blunt periodontal tip) following mechanical decontamination. The formulation contains Ac-KE-NH₂ at 150 µg/mL (NFκB suppression) and GHK at 500 µg/mL (soft tissue collar adaptation, collagen synthesis, antimicrobial activity). The two compounds address the two biological components mechanical therapy does not.
Mechanism vs antimicrobial adjuncts
Antimicrobial adjuncts (chlorhexidine irrigation, local antibiotics) extend the antimicrobial component of mechanical therapy. They do not address NFκB signaling or soft tissue collar competence. The OptiOral Seal mechanism is non-overlapping with antimicrobial adjuncts and not mutually exclusive with them in protocol design.
Citations
- Renvert S, Polyzois I. Treatment of peri-implant mucositis and peri-implantitis. Periodontol 2000. 2018;76(1):73-86.
- Schwarz F et al. Peri-implantitis surface decontamination — clinical evidence review. J Clin Periodontol. 2020.